Literature DB >> 12900741

Tl-201 myocardial SPECT in differentiation of ischemic from nonischemic dilated cardiomyopathy in patients with left ventricular dysfunction.

Yen-Wen Wu1, Ruoh-Fang Yen, Poon-Ung Chieng, Por-Jau Huang.   

Abstract

BACKGROUND: The differentiation between ischemic and nonischemic cardiomyopathy by noninvasive modalities is of clinical importance. Whether thallium 201 single photon emission computed tomography (SPECT) could accurately distinguish the two groups remains unclear. METHODS AND
RESULTS: Twenty-nine patients with chronic heart failure (left ventricular ejection fraction < or =40%), including fourteen patients with ischemic cardiomyopathy and fifteen patients with nonischemic dilated cardiomyopathy, underwent Tl-201 SPECT. The stress protocols included treadmill exercise in 8 patients, dipyridamole in 6 patients, and dobutamine infusion in 15 patients. Myocardial SPECT was interpreted with the use of a 17-segment model and 0- to 4-point scale system. Patients with ischemic cardiomyopathy had higher summed stress defect scores (27.9 +/- 9.4 vs 20.6 +/- 8.9, P =.04), more fixed defect segments (5.9 +/- 2.9 vs 3.8 +/- 2.9, P =.05), and more moderate or severe perfusion defect segments on stress scan (7.2 +/- 2.0 vs 4.5 +/- 2.6, P =.004) than did those with nonischemic dilated cardiomyopathy. However, considerable overlap of the scan patterns between the two groups existed. Moderate or severe perfusion defects on stress scan in at least 7 segments were noted in 71% of patients (10/14) with ischemic cardiomyopathy, as compared with 20% of patients (3/15) with nonischemic cardiomyopathy (P =.016).
CONCLUSIONS: Assessment of Tl-201 myocardial SPECT yields only modest value to distinguish nonischemic dilated cardiomyopathy from ischemic cardiomyopathy in patients with chronic heart failure. This technique cannot clearly differentiate individual patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900741     DOI: 10.1016/s1071-3581(03)00456-2

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  24 in total

Review 1.  Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease.

Authors:  G A Beller; B L Zaret
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

2.  201Tl SPECT abnormalities, documented at rest in dilated cardiomyopathy, are related to a lower than normal myocardial thickness but not to an excess in myocardial wall stress.

Authors:  Nathalie Hassan; Jean-Marie Escanyé; Yves Juillière; Pierre-Yves Marie; Nicolas David; Pierre Olivier; Adey Ayalew; Gilles Karcher; Jean-François Stolz; Alain Bertrand
Journal:  J Nucl Med       Date:  2002-04       Impact factor: 10.057

3.  Prognostic value of thallium-201 perfusion defects in idiopathic dilated cardiomyopathy.

Authors:  Y L Doi; T Chikamori; J Tukata; Y Yonezawa; J D Poloniecki; T Ozawa; W J McKenna
Journal:  Am J Cardiol       Date:  1991-01-15       Impact factor: 2.778

4.  Comparative study of 201Tl-scintigraphic image and myocardial pathologic findings in patients with dilated cardiomyopathy.

Authors:  L X Li; R Nohara; K Okuda; R Hosokawa; T Hata; M Tanaka; A Matsumori; M Fujita; N Tamaki; J Konishi; S Sasayama
Journal:  Ann Nucl Med       Date:  1996-08       Impact factor: 2.668

Review 5.  The evaluation of chest pain in women.

Authors:  P S Douglas; G S Ginsburg
Journal:  N Engl J Med       Date:  1996-05-16       Impact factor: 91.245

6.  Inhomogeneity of myocardial perfusion in heart transplant recipients: evaluation with dobutamine thallium-201 SPECT.

Authors:  R F Yen; Y L Ho; N K Chou; R B Hsu; P J Huang
Journal:  Nucl Med Commun       Date:  2001-09       Impact factor: 1.690

7.  Do beta-blockers affect the diagnostic sensitivity of dobutamine stress thallium-201 single photon emission computed tomographic imaging?

Authors:  P J Huang; R F Yen; P U Chieng; M L Chen; C T Su
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

8.  Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy.

Authors:  P G Danias; A W Ahlberg; B A Clark; F Messineo; M G Levine; C C McGill; A Mann; J Clive; J E Dougherty; D D Waters; G V Heller
Journal:  Am J Cardiol       Date:  1998-11-15       Impact factor: 2.778

9.  Dobutamine stress echocardiography compared with dipyridamole thallium-201 single-photon emission computed tomography in detecting coronary artery disease.

Authors:  F M Ho; P J Huang; C S Liau; F K Lee; P U Chieng; C T Su; Y T Lee
Journal:  Eur Heart J       Date:  1995-04       Impact factor: 29.983

10.  Thallium 201 imaging and gated cardiac blood pool scans in patients with ischemic and idiopathic congestive cardiomyopathy. A clinical and pathologic study.

Authors:  B H Bulkley; G M Hutchins; I Bailey; H W Strauss; B Pitt
Journal:  Circulation       Date:  1977-05       Impact factor: 29.690

View more
  14 in total

Review 1.  The role of radionuclide imaging in heart failure.

Authors:  Vinay Gulati; Gilbert Ching; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

2.  99 mTc-MIBI washout as a complementary factor in the evaluation of idiopathic dilated cardiomyopathy (IDCM) using myocardial perfusion imaging.

Authors:  Mohammad Kazem Shiroodi; Babak Shafiei; Nastaran Baharfard; Mohammad Esmail Gheidari; Babak Nazari; Elaheh Pirayesh; Ali Kiasat; Samaneh Hoseinzadeh; Abolghassem Hashemi; Mohammad Ali Akbarzadeh; Hamid Javadi; Iraj Nabipour; Majid Assadi
Journal:  Int J Cardiovasc Imaging       Date:  2010-12-28       Impact factor: 2.357

3.  It's not all in the numbers.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2015-03-24       Impact factor: 5.952

4.  Data-driven respiratory motion tracking and compensation in CZT cameras: a comprehensive analysis of phantom and human images.

Authors:  Chi-Lun Ko; Yen-Wen Wu; Mei-Fang Cheng; Ruoh-Fang Yen; Wen-Chau Wu; Kai-Yuan Tzen
Journal:  J Nucl Cardiol       Date:  2014-08-14       Impact factor: 5.952

5.  Thallium-201 myocardial SPECT in left bundle branch block: diagnosis of myocardial ischemia with a disease-specific reference database.

Authors:  Kristóf Zupán; Béla Kári; Géza Fontos; Péter Dékány; Oszkár Pártos
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

Review 6.  PET and SPECT in heart failure.

Authors:  Christoph Rischpler; Stephan Nekolla; Markus Schwaiger
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

7.  The Incremental Diagnostic Performance of Coronary Computed Tomography Angiography Added to Myocardial Perfusion Imaging in Patients with Intermediate-to-High Cardiovascular Risk.

Authors:  Pei-Ying Hsu; Wen-Jeng Lee; Mei-Fang Cheng; Ruoh-Fang Yen; Kai-Yuan Tzen; Yen-Wen Wu
Journal:  Acta Cardiol Sin       Date:  2016-03       Impact factor: 2.672

8.  QTc Heterogeneity in Rest Magnetocardiography is Sensitive to Detect Coronary Artery Disease: In Comparison with Stress Myocardial Perfusion Imaging.

Authors:  Yen-Wen Wu; Lung-Chun Lin; Wei-Kung Tseng; Yen-Bin Liu; Hsian-Li Kao; Mao-Shin Lin; Huei-Chun Huang; Shan-Ying Wang; Herng-Er Horng; Hong-Chang Yang; Chau-Chung Wu
Journal:  Acta Cardiol Sin       Date:  2014-09       Impact factor: 2.672

9.  Myocardial viability by contrast-enhanced cardiovascular magnetic resonance in patients with coronary artery disease: comparison with gated single-photon emission tomography and FDG position emission tomography.

Authors:  Yen-Wen Wu; Eiji Tadamura; Shotaro Kanao; Masaki Yamamuro; Akira Marui; Masashi Komeda; Masanao Toma; Takeshi Kimura; Kaori Togashi
Journal:  Int J Cardiovasc Imaging       Date:  2007-03-16       Impact factor: 2.357

10.  Serum Angiopoietin-Like Protein 2 Concentrations Are Independently Associated with Heart Failure.

Authors:  Chi-Lun Huang; Yen-Wen Wu; Chih-Cheng Wu; Juey-Jen Hwang; Wei-Shiung Yang
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.